TARDBP and amyotrophic lateral sclerosis: Our views about ALS pathogenesis are undergoing a paradigm shift triggered by the discovery that the pathogenic inclusions of TDP-43 presented in ~97% ALS and ~45% FTD patients regardless of being familial or sporadic [5].